SNW Stock Overview
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.
Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Rewards
Risk Analysis
Sanofi Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €86.33 |
52 Week High | €105.14 |
52 Week Low | €80.80 |
Beta | 0.45 |
1 Month Change | -2.21% |
3 Month Change | -9.10% |
1 Year Change | -15.05% |
3 Year Change | -0.71% |
5 Year Change | 16.16% |
Change since IPO | 17.15% |
Recent News & Updates
Recent updates
Shareholder Returns
SNW | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | -1.7% | -1.6% | -0.8% |
1Y | -15.0% | -29.6% | 1.0% |
Return vs Industry: SNW exceeded the German Pharmaceuticals industry which returned -29.6% over the past year.
Return vs Market: SNW underperformed the German Market which returned 1% over the past year.
Price Volatility
SNW volatility | |
---|---|
SNW Average Weekly Movement | 2.4% |
Pharmaceuticals Industry Average Movement | 7.0% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 9.9% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: SNW has not had significant price volatility in the past 3 months.
Volatility Over Time: SNW's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 86,088 | Paul Hudson | www.sanofi.com |
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.
Sanofi Fundamentals Summary
SNW fundamental statistics | |
---|---|
Market cap | €107.60b |
Earnings (TTM) | €5.40b |
Revenue (TTM) | €46.03b |
19.9x
P/E Ratio2.3x
P/S RatioIs SNW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SNW income statement (TTM) | |
---|---|
Revenue | €46.03b |
Cost of Revenue | €14.22b |
Gross Profit | €31.82b |
Other Expenses | €26.42b |
Earnings | €5.40b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 25, 2024
Earnings per share (EPS) | 4.32 |
Gross Margin | 69.12% |
Net Profit Margin | 11.73% |
Debt/Equity Ratio | 22.0% |
How did SNW perform over the long term?
See historical performance and comparisonDividends
4.4%
Current Dividend Yield87%
Payout RatioDoes SNW pay a reliable dividends?
See SNW dividend history and benchmarksSanofi dividend dates | |
---|---|
Ex Dividend Date | May 13 2024 |
Dividend Pay Date | May 15 2024 |
Days until Ex dividend | 25 days |
Days until Dividend pay date | 27 days |
Does SNW pay a reliable dividends?
See SNW dividend history and benchmarks